Cargando…

Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis

BACKGROUND: Diabetic retinopathy (DR) is a major sight-threatening diabetic complication. Previous studies have examined the association of DR with multiple genetic variants in the receptor for advanced glycation end products (RAGE) gene, with inconsistent results. OBJECTIVE: To perform a systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Weihong, Yang, Jingyun, Sui, Wenda, Qu, Bin, Huang, Ping, Chen, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265886/
https://www.ncbi.nlm.nih.gov/pubmed/27684793
http://dx.doi.org/10.1097/MD.0000000000004463
_version_ 1782500358201802752
author Yu, Weihong
Yang, Jingyun
Sui, Wenda
Qu, Bin
Huang, Ping
Chen, Youxin
author_facet Yu, Weihong
Yang, Jingyun
Sui, Wenda
Qu, Bin
Huang, Ping
Chen, Youxin
author_sort Yu, Weihong
collection PubMed
description BACKGROUND: Diabetic retinopathy (DR) is a major sight-threatening diabetic complication. Previous studies have examined the association of DR with multiple genetic variants in the receptor for advanced glycation end products (RAGE) gene, with inconsistent results. OBJECTIVE: To perform a systematic literature search and conduct meta-analyses to examine the association of genetic variants in RAGE with DR. DATA SOURCES: PubMed, Cochrane Library, Embase, Google Scholar, and HuGE. STUDY ELIGIBILITY CRITERIA AND PARTICIPANTS: Studies were on human subjects; the studies were case–control ones and included subjects who had DR and those who did not have DR; and the studies provided genotype data for genetic variants in RAGE, separately for subjects who had and did not have DR, or provided odds ratios (ORs) and the 95% confidence intervals (CIs), or provided sufficient data for the calculation of OR and the 95% CI. STUDY APPRAISAL AND SYNTHESIS METHODS: We used OR as a measure of association, and used random-effects model in all the meta-analyses. Between-study heterogeneity was assessed using I(2), and publication bias was evaluated using Egger test. RESULTS: A total of 13 studies met the eligibility criteria and were included in our analyses. We found that Gly82Ser was significantly associated with DR (OR = 2.40, 95% CI: 1.46–3.97; P = 0.001) using a recessive model. -374T/A also showed significant association with DR under a dominant model (OR = 1.21, 95% CI: 1.03–1.43; P = 0.023). We did not find a significant association of DR with other genetic variants in RAGE. LIMITATIONS: The number of included studies is small for some genetic variants; duration of diabetes varied across studies; most studies were conducted in Asia; and it is not clear whether the observed association can be generalized to other ethnicities; and we could not control for other potential confounding factors. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: We found that Gly82Ser in RAGE showed significant association with DR. More studies with larger sample sizes that control for important risk factors, such as duration of diabetes, are needed to validate our findings.
format Online
Article
Text
id pubmed-5265886
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-52658862017-02-06 Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis Yu, Weihong Yang, Jingyun Sui, Wenda Qu, Bin Huang, Ping Chen, Youxin Medicine (Baltimore) 5800 BACKGROUND: Diabetic retinopathy (DR) is a major sight-threatening diabetic complication. Previous studies have examined the association of DR with multiple genetic variants in the receptor for advanced glycation end products (RAGE) gene, with inconsistent results. OBJECTIVE: To perform a systematic literature search and conduct meta-analyses to examine the association of genetic variants in RAGE with DR. DATA SOURCES: PubMed, Cochrane Library, Embase, Google Scholar, and HuGE. STUDY ELIGIBILITY CRITERIA AND PARTICIPANTS: Studies were on human subjects; the studies were case–control ones and included subjects who had DR and those who did not have DR; and the studies provided genotype data for genetic variants in RAGE, separately for subjects who had and did not have DR, or provided odds ratios (ORs) and the 95% confidence intervals (CIs), or provided sufficient data for the calculation of OR and the 95% CI. STUDY APPRAISAL AND SYNTHESIS METHODS: We used OR as a measure of association, and used random-effects model in all the meta-analyses. Between-study heterogeneity was assessed using I(2), and publication bias was evaluated using Egger test. RESULTS: A total of 13 studies met the eligibility criteria and were included in our analyses. We found that Gly82Ser was significantly associated with DR (OR = 2.40, 95% CI: 1.46–3.97; P = 0.001) using a recessive model. -374T/A also showed significant association with DR under a dominant model (OR = 1.21, 95% CI: 1.03–1.43; P = 0.023). We did not find a significant association of DR with other genetic variants in RAGE. LIMITATIONS: The number of included studies is small for some genetic variants; duration of diabetes varied across studies; most studies were conducted in Asia; and it is not clear whether the observed association can be generalized to other ethnicities; and we could not control for other potential confounding factors. CONCLUSIONS AND IMPLICATIONS OF KEY FINDINGS: We found that Gly82Ser in RAGE showed significant association with DR. More studies with larger sample sizes that control for important risk factors, such as duration of diabetes, are needed to validate our findings. Wolters Kluwer Health 2016-09-30 /pmc/articles/PMC5265886/ /pubmed/27684793 http://dx.doi.org/10.1097/MD.0000000000004463 Text en Copyright © 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NoDerivatives License 4.0, which allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author. http://creativecommons.org/licenses/by-nd/4.0
spellingShingle 5800
Yu, Weihong
Yang, Jingyun
Sui, Wenda
Qu, Bin
Huang, Ping
Chen, Youxin
Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
title Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
title_full Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
title_fullStr Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
title_full_unstemmed Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
title_short Association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: A meta-analysis
title_sort association of genetic variants in the receptor for advanced glycation end products gene with diabetic retinopathy: a meta-analysis
topic 5800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5265886/
https://www.ncbi.nlm.nih.gov/pubmed/27684793
http://dx.doi.org/10.1097/MD.0000000000004463
work_keys_str_mv AT yuweihong associationofgeneticvariantsinthereceptorforadvancedglycationendproductsgenewithdiabeticretinopathyametaanalysis
AT yangjingyun associationofgeneticvariantsinthereceptorforadvancedglycationendproductsgenewithdiabeticretinopathyametaanalysis
AT suiwenda associationofgeneticvariantsinthereceptorforadvancedglycationendproductsgenewithdiabeticretinopathyametaanalysis
AT qubin associationofgeneticvariantsinthereceptorforadvancedglycationendproductsgenewithdiabeticretinopathyametaanalysis
AT huangping associationofgeneticvariantsinthereceptorforadvancedglycationendproductsgenewithdiabeticretinopathyametaanalysis
AT chenyouxin associationofgeneticvariantsinthereceptorforadvancedglycationendproductsgenewithdiabeticretinopathyametaanalysis